Single-site I-FP-CIT Reference Values from Individuals with Non-degenerative Parkinsonism-comparison with Values from Healthy Volunteers

Overview

Journal Eur J Hybrid Imaging

Date 2021 Jun 30

PMID 34191214

Citations 5

Authors

Rachid Fahmi

Gunther Platsch

Alexandre Bani Sadr

Sylvain Gouttard

Stephane Thobois

Sven Zuehlsdorff

Christian Scheiber

Affiliations

Soon will be listed here.

Abstract

Purpose: Iodine 123-radiolabeled 2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (I-FP-CIT) SPECT can be performed to distinguish degenerative forms of movement disorders/parkinsonism/tremor from other entities such as idiopathic tremor or drug-induced parkinsonism. For equivocal cases, semi-quantification and comparison to reference values are a necessary addition to visual interpretation of I-FP-CIT scans. To overcome the challenges of multi-center recruitment and scanning of healthy volunteers, we generated I-FP-CIT reference values from individuals with various neurological conditions but without dopaminergic degeneration, scanned at a single center on the same SPECT-CT system following the same protocol, and compared them to references from a multi-center database built using healthy volunteers' data.

Methods: From a cohort of 1884 patients, we identified 237 subjects (120 men, 117 women, age range 16-88 years) through a two-stage selection process. Every patient had a final clinical diagnosis after a mean follow-up of 4.8 ± 1.3 years. Images were reconstructed using (1) Flash3D with scatter and CT-based attenuation corrections (AC) and (2) filtered back projection with Chang AC. Volume-of-interest analysis was performed using a commercial software to calculate specific binding ratios (SBRs), caudate-to-putamen ratios, and asymmetry values on different striatal regions. Generated reference values were assessed according to age and gender and compared with those from the ENC-DAT study, and their robustness was tested against a cohort of patients with different diagnoses.

Results: Age had a significant negative linear effect on all SBRs. Overall, the reduction rate per decade in SBR was between 3.80 and 5.70%. Women had greater SBRs than men, but this gender difference was only statistically significant for the Flash3D database. Linear regression was used to correct for age-dependency of SBRs and to allow comparisons to age-matched reference values and "normality" limits. Generated regression parameters and their 95% confidence intervals (CIs) were comparable to corresponding European Normal Control Database of DaTscan (ENC-DAT) results. For example, 95% CI mean slope for the striatum in women is - 0.015 ([- 0.019, - 0.011]) for the Flash3D database versus - 0.015 ([- 0.021, - 0.009]) for ENC-DAT. Caudate-to-putamen ratios and asymmetries were not influenced by age or gender.

Conclusion: The generated I-FP-CIT references values have similar age-related distribution, with no increase in variance due to comorbidities when compared to values from a multi-center study with healthy volunteers. This makes it possible for sites to build their I-FP-CIT references from scans acquired during routine clinical practice.

Citing Articles

Dopaminergic PET to SPECT domain adaptation: a cycle GAN translation approach.

Lopes L, Jiao F, Xue S, Pyka T, Krieger K, Ge J Eur J Nucl Med Mol Imaging. 2024; 52(3):851-863.

PMID: 39557690 PMC: 11754385. DOI: 10.1007/s00259-024-06961-x.

Age and gender effects on striatal dopamine transporter density and cerebral perfusion in individuals with non-degenerative parkinsonism: a dual-phase F-FP-CIT PET study.

Kim J, Kang S, Moon B, Kim B, Jeong J, Yoon H EJNMMI Res. 2024; 14(1):65.

PMID: 39017925 PMC: 11254898. DOI: 10.1186/s13550-024-01126-1.

Investigating the aspect of asymmetry in brain-first versus body-first Parkinson's disease.

Lovdal S, Carli G, Orso B, Biehl M, Arnaldi D, Mattioli P NPJ Parkinsons Dis. 2024; 10(1):74.

PMID: 38555343 PMC: 10981719. DOI: 10.1038/s41531-024-00685-3.

Semi-quantitative analysis of visually normal I-FP-CIT across three large databases revealed no difference between control and patients.

Flaus A, Philippe R, Thobois S, Janier M, Scheiber C EJNMMI Res. 2023; 13(1):37.

PMID: 37117951 PMC: 10147889. DOI: 10.1186/s13550-023-00983-6.

Serial changes of I-123 FP-CIT SPECT binding asymmetry in Parkinson's disease: Analysis of the PPMI data.

Jeong E, Sunwoo M, Lee J, Han S, Hyung S, Song Y Front Neurol. 2022; 13:976101.

PMID: 36119683 PMC: 9474999. DOI: 10.3389/fneur.2022.976101.

References

Matsuda H, Murata M, Mukai Y, Sako K, Ono H, Toyama H . Japanese multicenter database of healthy controls for [I]FP-CIT SPECT. Eur J Nucl Med Mol Imaging. 2018; 45(8):1405-1416. PMC: 5993845. DOI: 10.1007/s00259-018-3976-5. View

Shin H, Kang S, Yang J, Kim H, Lee M, Sohn Y . Use of the Putamen/Caudate Volume Ratio for Early Differentiation between Parkinsonian Variant of Multiple System Atrophy and Parkinson Disease. J Clin Neurol. 2009; 3(2):79-81. PMC: 2686861. DOI: 10.3988/jcn.2007.3.2.79. View

Volkow N, Wang G, Newcorn J, Fowler J, Telang F, Solanto M . Brain dopamine transporter levels in treatment and drug naïve adults with ADHD. Neuroimage. 2006; 34(3):1182-90. DOI: 10.1016/j.neuroimage.2006.10.014. View

Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M . Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. J Nucl Med. 2000; 41(1):36-44. View

Tossici-Bolt L, Dickson J, Sera T, de Nijs R, Bagnara M, Jonsson C . Calibration of gamma camera systems for a multicentre European ¹²³I-FP-CIT SPECT normal database. Eur J Nucl Med Mol Imaging. 2011; 38(8):1529-40. DOI: 10.1007/s00259-011-1801-5. View

Barnden L, Dickson J, Hutton B . Detection and validation of the body edge in low count emission tomography images. Comput Methods Programs Biomed. 2006; 84(2-3):153-61. DOI: 10.1016/j.cmpb.2006.08.001. View

Neumeyer J, Wang S, Gao Y, Milius R, Kula N, Campbell A . N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. J Med Chem. 1994; 37(11):1558-61. DOI: 10.1021/jm00037a004. View

Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G . Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis. Neurology. 2016; 86(6):566-76. DOI: 10.1212/WNL.0000000000002350. View

Mozley P, Kim H, Gur R, Tatsch K, Muenz L, McElgin W . Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values. J Nucl Med. 1996; 37(12):1965-70. View

10.

Booij J, Speelman J, Horstink M, Wolters E . The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med. 2001; 28(3):266-72. DOI: 10.1007/s002590000460. View

11.

Nicastro N, Burkhard P, Garibotto V . Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study. J Neurol Sci. 2018; 385:17-21. DOI: 10.1016/j.jns.2017.11.039. View

12.

Catafau A, Tolosa E . Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord. 2004; 19(10):1175-82. DOI: 10.1002/mds.20112. View

13.

Haapaniemi T, Ahonen A, Torniainen P, Sotaniemi K, Myllyla V . [123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients. Mov Disord. 2001; 16(1):124-30. DOI: 10.1002/1531-8257(200101)16:1<124::aid-mds1007>3.0.co;2-r. View

14.

Varrone A, Dickson J, Tossici-Bolt L, Sera T, Asenbaum S, Booij J . European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging. 2012; 40(2):213-27. DOI: 10.1007/s00259-012-2276-8. View

15.

Soderlund T, Dickson J, Prvulovich E, Ben-Haim S, Kemp P, Booij J . Value of semiquantitative analysis for clinical reporting of 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies. J Nucl Med. 2013; 54(5):714-22. DOI: 10.2967/jnumed.112.110106. View

16.

El Fakhri G, Habert M, Maksud P, Kas A, Malek Z, Kijewski M . Quantitative simultaneous (99m)Tc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging. 2005; 33(1):87-92. DOI: 10.1007/s00259-005-1920-y. View

17.

Djang D, Janssen M, Bohnen N, Booij J, Henderson T, Herholz K . SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med. 2011; 53(1):154-63. DOI: 10.2967/jnumed.111.100784. View

18.

Nobili F, Naseri M, De Carli F, Asenbaum S, Booij J, Darcourt J . Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database. Eur J Nucl Med Mol Imaging. 2012; 40(4):565-73. DOI: 10.1007/s00259-012-2304-8. View

19.

Dickson J, Tossici-Bolt L, Sera T, de Nijs R, Booij J, Bagnara M . Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123I-FP-CIT SPECT database. Eur J Nucl Med Mol Imaging. 2011; 39(1):188-97. DOI: 10.1007/s00259-011-1884-z. View

20.

Booij J, Andringa G, Rijks L, Vermeulen R, De Bruin K, Boer G . [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys. Synapse. 1997; 27(3):183-90. DOI: 10.1002/(SICI)1098-2396(199711)27:3<183::AID-SYN4>3.0.CO;2-9. View